Stock Information
Incyte Corp (INCY)
Ticker Symbol: INCY
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $18,833.24 mil
Piotroski score: 7
PE Ratio: 14.9699
EPS (TTM): 6.4047
Revenue (TTM): $25.13 M
Dividend Yield: N/A%
ROE: 29.15%
Latest News
-
Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease
Fri, May 1, 2026 9:28 PM
-
Earnings Beat: Incyte Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Fri, May 1, 2026 11:12 AM
-
Incyte: Strong Business, But Risks Remain
Fri, May 1, 2026 11:08 AM
-
Oppenheimer Maintains Perform on Incyte, Raises Price Target to $90
Wed, Apr 29, 2026 12:36 PM
-
Incyte to Present at Upcoming Investor Conferences
Wed, Apr 29, 2026 12:00 PM
-
Company News for Apr 29, 2026
Wed, Apr 29, 2026 8:41 AM
-
Incyte Corp (INCY) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Promising ...
Wed, Apr 29, 2026 7:03 AM
-
Incyte Corporation 2026 Q1 - Results - Earnings Call Presentation
Tue, Apr 28, 2026 10:32 PM
-
Incyte (INCY) Q1 2026 Earnings Call Transcript
Tue, Apr 28, 2026 5:07 PM
-
Incyte (INCY) Q2 2025 Earnings Transcript
Tue, Apr 28, 2026 5:04 PM
Key Financials
Financial data not available
